HAL vs NERV · P/E 9.3, $19.05B cap vs P/E 2.2, $12.4M cap
Halliburton Company (HAL) versus Minerva Neurosciences Inc (NERV) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported NERV revenue for 2024-12-31 was $0. Net income was $1.4M. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
Not investment advice. Open the HAL and NERV stock pages for the full models.
Not investment advice.